Centric Wealth Management Maia Biotechnology, Inc. Transaction History
Centric Wealth Management
- $329 Million
- Q2 2024
A detailed history of Centric Wealth Management transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Centric Wealth Management holds 68,198 shares of MAIA stock, worth $184,816. This represents 0.07% of its overall portfolio holdings.
Number of Shares
68,198
Previous 67,198
1.49%
Holding current value
$184,816
Previous $147,000
58.5%
% of portfolio
0.07%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding MAIA
# of Institutions
22Shares Held
1.79MCall Options Held
0Put Options Held
0-
Halter Ferguson Financial Inc. Carmel, IN722KShares$1.96 Million1.75% of portfolio
-
Vanguard Group Inc Valley Forge, PA537KShares$1.46 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA157KShares$424,7700.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$212,7910.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX45.7KShares$123,8470.0% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $29.6M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...